Rachel Williamson US oil production is back but future looks tight August 18, 2020 US oil producers have been rapidly bringing wells back online since June but with drilling rig counts still at multi-decade… G Medical to delist from ASX despite a May promise to stay August 17, 2020 With its stock plumbing all time lows, G Medical (ASX:GMV) is making good on a promise first made in 2018… Scopo’s powerplays: Investors love an ice queen August 14, 2020 Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains… Osprey gets European tick of approval for latest device August 13, 2020 Osprey Medical (ASX:OSP) has received European regulatory approval for its second generation DyeVert Power XT device. The CE Marking means… Corporate deals backstopping Aussie renewables, already beating 2019 August 12, 2020 LNG is out of favour and coal demand is well down, yet corporate renewable energy deals in Australia are already… Regeneus finally signs that Japan stem cell deal, shares jump 81pc August 11, 2020 Regeneus (ASX:RGS) has finally done that deal with Kyocera Corporation to develop and commercialise its stem cell treatment Progenza for… All of 1300 Smiles’ Jobkeeper subsidy has gone on its dividend August 11, 2020 Jobkeeper subsidies will make up two thirds of dental group 1300 Smiles' (ASX:ONT) final dividend at 12.5c payout. The company… What ASX investors should look for in a COVID-19 earnings season August 11, 2020 Forward guidance and an ability to meet revised forecasts following the start of the COVID-19 pandemic are what analysts and… Growth stocks still winning in war with value August 10, 2020 The current vogue for growth stocks over value investments is akin to the years leading to 2000 just before the… Scopo’s powerplays: Strap yourselves in for some M&A August 7, 2020 Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains… Advance Nanotek boss reiterates threat to quit the ASX August 6, 2020 "We're sorry." Two words rarely heard from company boards, and even more rarely in annual reports. But Lev Mizikozsky, chairman… Check up: Maybe next week will be better? August 6, 2020 Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 133-odd small cap health stocks… Could Inventis’ chair-as-a-service be the tip of a turnaround story? August 4, 2020 The COVID-19 pandemic has given the world many things -- telehealth, gold millionaires, maybe even a successful NSX -- and… Will it take a pandemic to make Aussie secondary markets successful? August 4, 2020 A viable alternative to the ASX has long been a goal for several business groups, but trading markets for companies… Prescient, Antisense the only green shoots in a sea of red August 3, 2020 On a morning steeped in red, Prescient Therapeutics (ASX: PTX) and Antisense Therapeutics (ASX:ANP) were two of the few companies… Scopo’s powerplays: Hemp hippies and wellness wonderlands July 31, 2020 Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains… This is how Australia’s energy market will evolve over the next 20 years: AEMO July 30, 2020 A two decade plan for the energy market could deliver $11bn worth of net benefits if Australia takes the "least… Next» « Previous